Genovis AB (publ.) (GENO.ST)

SEK 25.0

(2.04%)

Eps Summary of Genovis AB (publ.)

  • Genovis AB (publ.)'s latest annual eps in 2023 was 0.94 SEK , up 452.94% from previous year.
  • Genovis AB (publ.)'s latest quarterly eps in 2024 Q1 was 0.19 SEK , up 3068.75% from previous quarter.
  • Genovis AB (publ.) reported an annual eps of 0.17 SEK in 2022, down -55.26% from previous year.
  • Genovis AB (publ.) reported an annual eps of 0.38 SEK in 2021, up 283.84% from previous year.
  • Genovis AB (publ.) reported a quarterly eps of 0.19 SEK for 2024 Q1, up 3068.75% from previous quarter.
  • Genovis AB (publ.) reported a quarterly eps of 0.67 SEK for 2023 Q1, up 709.09% from previous quarter.

Annual Eps Chart of Genovis AB (publ.) (2023 - 2008)

Historical Annual Eps of Genovis AB (publ.) (2023 - 2008)

Year Eps Eps Growth
2023 0.94 SEK 452.94%
2022 0.17 SEK -55.26%
2021 0.38 SEK 283.84%
2020 0.10 SEK -34.0%
2019 0.15 SEK 643.48%
2018 -0.03 SEK 80.29%
2017 -0.14 SEK 56.25%
2016 -0.32 SEK 51.52%
2015 -0.66 SEK 31.96%
2014 -0.97 SEK -27.63%
2013 -0.76 SEK 42.86%
2012 -1.33 SEK 13.64%
2011 -1.54 SEK 28.37%
2010 -2.15 SEK 71.75%
2009 -7.61 SEK 55.96%
2008 -17.28 SEK 0.0%

Peer Eps Comparison of Genovis AB (publ.)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 270.909%
Ziccum AB (publ) -1.54 SEK 161.039%
Modus Therapeutics Holding AB (publ) -1.01 SEK 193.069%
BioArctic AB (publ) 2.60 SEK 63.846%
Sprint Bioscience AB (publ) -0.01 SEK 15020.635%
Mendus AB (publ) -4.40 SEK 121.364%
Intervacc AB (publ) -1.69 SEK 155.621%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 527.273%
Active Biotech AB (publ) -0.17 SEK 652.941%
Magle Chemoswed Holding AB (publ) 1.13 SEK 16.814%
Bio-Works Technologies AB (publ) -1.57 SEK 159.873%
Aptahem AB (publ) -0.05 SEK 2046.17%
Vicore Pharma Holding AB (publ) -3.22 SEK 129.193%
Kancera AB (publ) -0.80 SEK 217.5%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 109.447%
Fluicell AB (publ) -0.24 SEK 491.667%
Saniona AB (publ) -1.29 SEK 172.868%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 594.737%
Biovica International AB (publ) -2.14 SEK 143.925%
Spago Nanomedical AB (publ) -0.43 SEK 318.605%
AcouSort AB (publ) -1.29 SEK 172.868%
Xintela AB (publ) -0.13 SEK 823.077%
Abliva AB (publ) -0.09 SEK 1139.823%
Egetis Therapeutics AB (publ) -1.27 SEK 174.016%
Karolinska Development AB (publ) 0.02 SEK -4600.0%
OncoZenge AB (publ) -1.36 SEK 169.118%
Amniotics AB (publ) -0.01 SEK 8645.455%
2cureX AB (publ) -1.85 SEK 150.811%
CombiGene AB (publ) -1.80 SEK 152.222%
Asarina Pharma AB (publ) -0.57 SEK 264.912%
Calliditas Therapeutics AB (publ) -8.69 SEK 110.817%
Camurus AB (publ) 7.78 SEK 87.918%
Corline Biomedical AB -0.08 SEK 1216.39%
IRLAB Therapeutics AB (publ) -3.43 SEK 127.405%
Isofol Medical AB (publ) -0.23 SEK 508.696%
I-Tech AB 1.70 SEK 44.706%
Hansa Biopharma AB (publ) -15.83 SEK 105.938%
Cyxone AB (publ) -0.22 SEK 527.273%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 147.475%
Biosergen AB -0.60 SEK 256.667%
Cantargia AB (publ) -1.65 SEK 156.97%
NextCell Pharma AB -1.03 SEK 191.262%
Xspray Pharma AB (publ) -6.76 SEK 113.905%
Elicera Therapeutics AB (publ) -0.83 SEK 213.253%
Nanologica AB (publ) -2.05 SEK 145.854%
SynAct Pharma AB -6.64 SEK 114.157%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 461.538%
Stayble Therapeutics AB (publ) -0.92 SEK 202.174%
LIDDS AB (publ) -0.63 SEK 249.206%
Lipum AB (publ) -4.45 SEK 121.124%
BioInvent International AB (publ) -5.02 SEK 118.725%
Alzinova AB (publ) -0.41 SEK 329.268%
Oncopeptides AB (publ) -1.96 SEK 147.959%
Pila Pharma AB (publ) -0.47 SEK 300.0%
Guard Therapeutics International AB (publ) -11.26 SEK 108.348%
Scandinavian ChemoTech AB (publ) -1.13 SEK 183.186%
Simris Alg AB (publ) -0.16 SEK 687.5%
Diamyd Medical AB (publ) -1.60 SEK 158.75%
Xbrane Biopharma AB (publ) -1.27 SEK 174.016%
Ascelia Pharma AB (publ) -3.24 SEK 129.012%
Diagonal Bio AB (publ) -0.32 SEK 393.75%